The National Toxicology Program (NTP) has reported female mice fed high doses of Nitrofurantoin (NFI') were found to have ovarian atrophy as diagnosed histologically and increased benign ovarian tumors after 24 months of exposure (30). This result contrasts with 4 other recent carcinogenicity assays in rodents with NFI', all with no evidence of an ovarian effect. An extensive database documents benign tubular adenomas develop secondary to ovarian atrophy in many mouse strains, including B6C3F, (see ref 11). The present study was initiated to confirm this mechanism could be responsible for the ovarian tumors in the NTP study and to investigate the time course of ovarian changes seen in female B6C3F, mice. Mice were provided diet containing NFT at doses of 350 and 500 mgkg body weighvday and examined after 4, 8, 13, 17,43 and 64 weeks. A dose-related decrease in feed consumption, feed efficiency and body weight gain was seen and persisted throughout the study. Sexual maturity was delayed in a dose-related fashion, compatible with previously reported effects of reduced food consumption in rodents (12, 16). All groups of mice eventually did have normal estrous cycles, but cycle lengths were increased in a dose-related fashion. Both doses of NFT resulted in histological evidence of senile ovarian atrophy by week 43. Based on the reported association between sterility and ovarian tumors, we conclude the benign tubular adenomas seen at 2 yr in the NTP carcinogenicity study with NFT were secondary to the ovarian atrophy induced in this strain of mouse and not an indication NFI', itself, is a carcinogen.
INTRODUC~ION
Nitrofurantoin, 1-[[(5-nitro-2-furanyl)methylene]amino]-2, 4 imidazolidinedione (NFT), has been used extensively for the past 25 yrs for the treatment of bacterial urinary tract infections. Its rapid absorption following oral administration, minimal biotransformation, high solubility and excretion in the urine results in effective antibacterial concentrations in the urine (4). NFT is particularly effective for this indication because susceptible bacteria are not able to develop resistance (2).
General reproduction, perinatal-postnatal and teratology studies in rats and rabbits using up to 6 times the daily human therapeutic dose of NFT have shown no adverse effects in mother, fetus or neonate (23) . Early studies in Holtzman rats (17) and Sprague-Dawley rats (3) indicated NFT was not a carcinogen. Genetic toxicity studies have demonstrated that NFT can have mutagenic and clastogenic effects in bacterial and in some mammalian cell culture systems (7, 15, 30) ; however, these observations are not consistent across different bacterial and mammalian cell types. Evidence for cytogenic and unspecified DNA damage after in vivu administration has been reported but, similar to the in vitro situation, this has not been a consistent observation (9, 22, 24, 30) . A 2-yr carcinogenicity study in BDFl mice fed NFT as 0.075% and 0.3% of their diet revealed NFT was not carcinogenic in mice (10). More recently, 2-yr feeding studies in Sprague-Dawley rats at doses up to 49 mg/kg/day (28) and in Swiss mice at doses up to 200 mg/kg/day (29) reported NFT was not tumorigenic. The National Toxicology Program (NTP) has studied the toxicologic and carcinogenic properties of NFT in both sexes of Fischer 344 rats and B6C3FI mice (30). In their 90-day dose-range-finding studies, doses of NFT equal to or greater than 0.13% and 0.25% of the diet in male mice and rats, respectively, produced degeneration of germinal epithelium of the testis. Necrosis of ovarian follicles was produced at doses equal to or greater than 0.5% in female rats and mice. For the 2-yr carcinogenicity study, NFT was administered as 0 . 1 3~~ and o .~~o /~ of diet to male rats and male and female mice, and 0.6% and 0.13% of the diet to female rats. Reproductive effects produced by maximally tolerated doses of NFT for 2 yrs were increased incidences of testicular tubular degeneration at the high dose in both species, and ovarian atrophy, that is a complete lack of follicles and corpora lutea, in all female mice evaluated. Benign ovarian tumors classified as tubular adenomas and benign mixed tumors occurred with increased frequency in the high-dose female mice.
These benign ovarian tumors, usually grouped as tubular adenomas, have been produced in many strains of mice, including the B6C3FI, using a variety of experimental procedures all of which result in atrophy of the ovary with an intact pituitary. Examples include, genetic lack of oocytes (1 8), neonatal thymectomy (2 l), transplantation of the ovary into the spleen (8), and radiation (6). The time required for tumor formation appears to depend upon the strain of mouse but benign tubular adenomas have been reported in genetically-sterile B6C3Fl mice as early as 22 weeks of age (18). Because all B6C3F, mice receiving NFT in the NTP study were sterile at 2 yrs, the benign ovarian tumors appeared to have occurred secondarily to this process. Since sterility had not previously been observed in animals exposed to NFT, this study was designed to determine the onset and nature of NFT induced ovarian effects and to determine the progression of the lesions as a function of dose and duration of treatment in female B6C3Fl mice.
METHODS
Three hundred female and 20 male weanling B6C3Fl mice were obtained from Charles River Breeding Laboratories (Portage, MI). Females were housed individually in wire bottom, suspended steel cages. Males were housed in alley-type cages located between the rows of female cages to optimize normal reproductive function of the females. Mice were acclimatized for 13 days. At the end of the acclimation period, all animals exhibiting disease or physical abnormalities were discarded. The remaining females were randomly placed into 4 groups of 70 mice such that the mean weight of each group was similar. During the last 3 days of the acclimation period, average food consumption of 20 randomly selected females was used to determine the concentration of NFT needed in the diet for the first week of treatment. Subsequently, the percent of NFT needed was determined by the average feed consumption and body weights from the previous week for each group individually.
Group 1 consisted of controls which together with all 20 males were fed the basal diet. Groups 2, 3 and 4 received the basal diet containing the appro-priate percentage (w/w) of NFT to deliver respective doses of 350,500 or 750 mg NFT/kg bw/day. Mice in Group 4 refused to eat even when the dose for this group was reduced to 625 m a g bw/day, this led to rapid moribundity and mortality, although all surviving animals recovered rapidly when placed on control diet. As a result, all animals in Group 4 were omitted from the study on the 19th test day. The final study as reported here consisted of 3 groups of females; Group 1 (controls), Group 2 (350 mg dose), and Group 3 (500 mg dose). Crystalline nitrofurantoin monohydrate was obtained from Eaton Laboratories, Inc. (Norwich Eaton Pharmaceuticals, Inc., Norwich, NY). Diets were prepared on a weekly basis using as the basal diet Purina Certified Rodent Chow #5002. Each diet was admixed to homogeneity as initially established by multiple sample analyses of the mixture and by subsequent analysis at 12 week intervals thereafter. Due to a recognized effect of uv light on NFT, the shipment and storage of the compound was in uv-light excluding containers and diet mixing was done in the dark. Prior to the study uv-light intensity was measured in representative animal cages and was found to be low enough to have no significant effect on stability of the test compound.
The animals were given access to the diet and tap water ad libitum. Diets were provided in feeder jars with stainless steel inserts with 2 glass marbles placed on top of the diet to reduce feed wastage. Jars were filled daily, if needed, and at weekly intervals, a clean jar with fresh diet was provided. Each mouse was observed daily for evaluation of general health, physical activity and signs of toxicity. Individual body weights were recorded upon arrival, during the baseline period, at randomization and at weekly intervals thereafter. Individual feed consumption records were maintained during the baseline collection period and weekly thereafter. Animals were on a 121 12 light cycle during the study.
Beginning at 5 1 days of age, vaginal smears from subgroups of 10 females randomly selected from each dose group were prepared and immediately evaluated for estrous cycle state. Smears were examined daily for 14 days every 30 days. The same subgroups were used for this examination throughout the study. Classification of the estrous cycle was according to Long and Evans (1 3), and the definition of valid estrous cycles for calculation of cycle length was done according to Nelson et a1 (1 9).
Ten female mice from each group were sacrificed at 4, 8, 13, 17 , and 43 weeks by exposure to ether, necropsied, body, brain, uterus and ovarian weights were recorded and tissues selected for histologic evaluation. The remainder of the animals were terminated at study week 64 at which time the mice were 69 to 70 weeks of age. Tissues selected for histologic examination included brain, thyroid, adrenal gland, pituitary, kidney, liver, thymus, ovary, uterus, vagina and inguinal mammary gland as well as lesions that appeared to be treatment-related. Formalin-fixed tissues were routinely processed and stained with hematoxylin and eosin except as noted below. Early in the study, one section was examined from approximately the central portion of the left ovary, at the last 2 sacrifice times 3 step sections were examined from the left ovary. Histological examination of the primary and secondary reproductive organs was used to evaluate the stage of the estrous cycle according to the methods of Long and Evans (1 3). Statistical analyses of feed consumption, body weight gain, feed efficiency, and organ and body weight data included both normal distribution and distribution-free techniques. If Bartlett's test for homogeneity of variance was not significant, comparisons with the control group and other specific, pairwise comparisons of groups were based on the least significant difference criterion. If Bartlett's test was significant, these comparisons were based on Wilcoxon's rank sum test. All statistical tests were conducted at a 5%, two-sided risk level. Significance at the 1% and 0.1% levels is also indicated where appropriate (5, 26).
Mortality, Growth, Feed Consumption and Clinical 0 bservat ions
Mice fed 750 mg/kg NFT and subsequently 650 mgkg NFT refused to eat and became moribund and were, therefore, removed from the study. During the course of the study, one mouse in the 500 m a g NFT treatment group (Group 3) was found dead, cause of death not determined, while no mice died in the 350 mg/kg NFT treatment group (Group 2) or the control (Group 1). The body weights, cumulative feed consumption and feed efficiencies are summarized in Figs. 1, 2 and 3, respectively. The treated mice at both dose levels gained significantly less weight, consumed significantly less feed and had significantly lower feed efficiency ratios in a doserelated manner than the control mice. These growth No. examined 10 9 I 1 10 10 10 9 10 9 10 10 10 10 10 7 20 19 18 10 2 1 19 0 2 Intermediate follicles 10 9 1 1 10 9 10 9 10 9 10 10 10 10 3 1 19 0 0
RESULTS
Increased intermediate follicles 0 
Primordial follicles were present but not scored in all mice through week 17.
Based on examination of the uterus, vagina and mammary gland as well as ovaries using criteria of Long and Evans (13) .
h Indicates this diagnosis was not made on any animals at the time period indicated. and feed effects were noted early in the study and persisted to the end.
Female mice in Group 3 showed an increased incidence of closure of the vulva, consistent with delayed puberty, beginning shortly after initiation of the study and increasing to 52% by week 6. The incidence then decreased to 3% by week 19. covery of cyclic activity. Several mice in both treated groups were in proestrus and over one half the mice were in metestrus indicating that ovulation had taken place. Only in Group 3 were any mice still in diestrus. There continued to be a dose-related increase in the number of atretic follicles, but fewer mice were affected than at 4 weeks.
Functional and Morphological Evaluation of the Reproductive Organs
Histopathological findings are presented in Table  I . After 4 weeks on the diet, histologic examination revealed a dose-related decrease in old corpora lutea and an increase in intermediate and atretic follicles. The vaginal epithelium of the Group 3 mice showed a decrease in thickness and cornification consistent with the lack of mature follicular development and the uteri had reverted to the prepubertal phase. Vaginal smears also indicated the animals were in diestrus; however, the ovaries still had a low level of follicular development. In Group 2, there was interference in estrous cycling as indicated by greater numbers of animals in proestrus as compared to controls.
At 8 weeks, there was histologic evidence of re-By 13 weeks, the reproductive tissues from both treated groups were histologically indistinguishable from the controls. At 17 weeks, subtle treatment associated differences between treated and control animals were again detected. These consisted of slightly fewer corpora lutea, both old and new, and an increase in the degree of vaginal epithelial cornification and thickness in the treated animals. Treated animals were judged to be in proestrus more often than controls using histological criteria.
At 43 weeks, the ovaries of both treated groups had few or no primordial or intermediate follicles remaining. The numbers of corpora lutea were reduced in Group 3, and there was an increased incidence ofatretic follicles observed in Group 2. Mice in all groups were noted to be hormonally out of phase and uterine changes consisting of cystic endometrial hyperplasia were noted in mice in all 
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Average cycle exhibiting cycles length in days. groups. This change is consistent with an increase in endogenous estrogen, and is evidence that all mice, including controls, are beginning to show normal age-related hyperestrogenism. The change was greatest in Group 2 and least in Group 3. An increased incidence of maximal epithelial growth and cornification of the vaginal epithelium was noted in treated animals when compared to controls. At week 64, control mice continued to show varying degrees of primordial and developing follicles, and old and new corpora lutea. Correlative cyclic changes associated with the estrous cycle were present in the uterus and vagina of controls. Ovaries from treated mice were devoid of primordial follicles and showed no evidence of follicular or corpora luteal activity. In appearance, these ovaries were consistent with the morphological features of an ovary affected by senile atrophy. Histological changes in the uterus and vagina of treated mice indicated persistent proestrus or persistent diestrus, consistent with hormonal changes normally associated with Week 8
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senile ovarian atrophy. A granulosa cell tumor was seen in one Group 2 mouse at 64 weeks and a cervical leiomyosarcoma was noted in one mouse in Group 3. Throughout the study, the vaginal smear data, Table 11 , were consistent with the histologic findings. At the end of the 4th week, both treated groups showed a dose-related decrease in cycling. The cycling rate in treated mice recovered slowly and began to approach the controls by week 15. In Group 3, particularly, many mice continued to show prolonged periods of diestrus throughout this interval. After week 43, a progressive decline in cycling occurred in both dose groups. Initially, particularly in Group 2, this decline began as an increase in the length of proestrus, evidenced by smears having cornified cells with infiltrating leukocytes. With time the smears became primarily composed of leukocytes, indicating diestrus. By week 60, none of the treated animals were cycling whereas the controls continued to cycle at regular intervals. No data are presented for study week 27 because an inadvertent change in light cycle caused a large percentage of the animals to enter pseudopregnancy.
The necropsy body weights and reproductive organ weights, both absolute and as a percent of brain weight are presented in Table 111 . The difference between groups in necropsy body weights closely mirrored test-substance-related changes seen in weekly body weights reported in Fig. 1 . Reproductive organ size correlated with histopathological changes. Decreased absolute and relative uterine weights were seen in Group 3 at 4 and 8 weeks correlating with the reported prepubertal state, and at 43 and 65 weeks correlating with the premature senility reported. Absolute and relative uterine weights were also decreased in Group 2 at week 4, correlating with the reported prepubertal state and week 65 correlating with the senile atrophy. Decreases in absolute and relative ovarian weights were seen at week 64 in both dose groups correlating with senile ovarian atrophy noted on histopathology and in the vaginal smear data.
DISCUSSION No increase in mortality was observed in female mice fed up to 0.5% NFT in the NTP 90-day subchronic toxicity study (30). This dose corresponds to approximately 1 g/kg bw/day NFT. In the study reported here, female mice given a diet containing either 750 or 600 mg/kg bw/day NFT did not survive. The cause of mortality appeared to be primarily related to decreased food consumption, since mice ate very little and recovered very rapidly when control diet was provided. Two differences between the studies might explain these disparate results, feed consumption and housing conditions. The NTP reports feed consumption was slightly increased in the mice fed 0.5% NFT. It may be NFT mixed with their NIH-07 diet is more palatable, but it seems more likely this apparent increase was due to feed wastage since a 50% decrease in body weight gain was reported in the 0.5% dose group in the 90-day NTP study. The feeders in our study were designed to minimize wastage. Thus, it is not clear if the difference in food consumption is real. However, the difference in housing conditions would be very significant if the mice were indeed consuming very little food. Mice in the NTP study were group housed in shoebox cages, while mice in our study were individually housed in hanging wire cages and would be expected to require more calories to maintain body temperature. Although it has not been proven, we believe the differences in housing are the most likely cause for difference in mortality between the two studies.
Throughout our study, decreased food consumption and feed efficiency were seen in both surviving NFT groups. The decrease in feed efficiency may indicate some slight toxic effect of NFT at these high doses. As a result of these changes, body weight gain was significantly reduced in both dose groups. This resulted in a delay of sexual maturation, particularly in Group 3. The delay is similar to that seen with feed restriction alone (1 2, 16) . Food deprivation results in a decrease in gonadotropin releasing hormone which affects luteinizing hormone secretion (1). This results in a decrease in ovulation and an increase in atresia of growing follicles (12, 16, 20) . The reported effect on primordial follicles is less clear and may depend upon the duration of food restriction, species, and/or levels of gonadotropin secretion (1 6). The reported effects of food restriction correlate well with the changes seen on vaginal smears and histopathology during the first 3 months of the study. Although the Group 3 mice eventually began to cycle, their cycles were more likely to be abnormally prolonged. It is not clear if this latter effect is primarily due to NFT or secondary to their poor feed consumption and small body size.
In addition to delayed maturation, administration of NFT resulted in early onset of reproductive senescence. At 43 and 65 weeks, there was a decrease in the number of follicles with the ovaries resembling those of reproductively senescent older mice. This correlates with the observed decrease in cycling. The cause of early reproductive senility was not apparent but may have been associated with depressed levels of gonadotropin secretion which resulted in a more rapid utilization of primordial follicles. The decreased food consumption may be involved by increasing atresia of the growing folli-TOXICOLOGIC PATHOLWY cles. A direct toxic effect of NFT on the follicles, either the oocytes themselves or on the surrounding . ovarian tumors in the NTP study were secondary to the ovarian atrophy which occurs with NFT granulosa cells may also be involved since primordial follicles have been reported to be spared during food deprivation in other strains of mice (20) . Also, necrosis of ovarian follicular epithelial cells was seen in both rats and mice in the NTP 90-day studies (14) . It is also possible NFT is exerting an effect at the hypothalamic or pituitary level or the cause is some combination of these effects. In order to establish whether the action of NFT is a direct toxicity or a secondary to nutritional or hormonal effects, additional information such as hormone levels and mechanisms of cellular damage are needed. In vitro studies have been used to study the mechanisms of the rare NFT-associated drug reactions in lung and liver (25, 27) and similar studies may help clarify whether the action on the murine ovary is direct or indirect and explain the strain and species differences observed.
The mice in the current study developed nonfunctioning, atrophic ovaries as early as 43 weeks on test. This finding is very important in understanding the ovarian tumors reported in the NTP carcinogenicity study. Benign ovarian tumors of the types seen in the NTP study have been reported in mice made sterile from a variety of causes, including procedures which do not involve exposure to any known carcinogen, such as surgical manipulation of the ovary (8), immune destruction of the ovary (2 l), and genetic sterility (18). The benign tubular adenomas arise weeks to months after the animals become sterile, and apparently result from constant FSH and LH stimulation of the ovary once feedback inhibition by estrogen is blocked. In genetically sterile B6C3Fl mice, tubular adenomas are reported to appear by 22 weeks of age (1 8). The tumors are seen rarely in normal 2-yr-old mice because most of these mice still have a few functioning follicles. Since NFT given at these doses to this strain of mice causes sterility prior to one year on test, an increase in these sterility-induced ovarian tumors would be expected.
In 2 other mouse carcinogenicity studies using Swiss (29) and BDl (10) mice, administration of NFT was not reported to cause ovarian atrophy. Why ovarian toxicity occurs in the B6C3Fl mouse and not in the 2 other strains is not known. Importantly, no increases in ovarian tumors were reported in these 2 studies. Neither ovarian atrophy or tumors were reported in carcinogenicity studies in Fischer 344 (30) and Sprague-Dawley rats (28).
Based on the extensive literature detailing sterility induced benign ovarian tumors of the type seen in the NTP study, the uniform induction of early sterility in B6C3Fl mice, and the lack of ovarian atrophy or tumors in 4 other rodent studies, we feel the administration in this strain of mouse. The tumors are not evidence that the compound itself is a carcinogen.
